Jacquelynn Golubov

4PUBLICATIONS
69CO-AUTHORS
Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 06, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.

Christopher D Petro, Andrea T Hooper, Avery Peace

|Jun 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.

Janelle C Waite, Bei Wang, Lauric Haber

|Jan 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.

Dimitris Skokos, Janelle C Waite, Lauric Haber

|Nov 04, 2018
Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8.

Bei Wang, Wen Zhang, Vladimir Jankovic

Pageof 1